Posts by Li Feng
Immunotherapy has emerged as one of the most promising mechanisms to combat diseases like cancer and microbial infections. Since 2000, multiple antibody drugs have reached blockbuster status, including …
is a Partner at Finnegan who focuses her practice on patent litigation before U.S. district courts, post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), patent prosecution, opinions and counseling, and due diligence. Her technical experience spans a broad range of technologies, including pharmaceutical, biotechnology, medical device, chemical, agriculture, nanotechnology, cosmetic, and metallurgy. Dr. Feng has represented a number of pharmaceutical companies in Abbreviated New Drug Application (ANDA) litigation, conducting analysis and developing validity, infringement, and enforcement positions. She also frequently speaks on intellectual property topics.
For more information, or to contact Dr. Feng, please visit his Firm Profile Page